BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Pasquale F. Innominato, René Adam. Use of Bevacizumab in the Management of Potentially Resectable Colorectal Liver Metastases: Safety, Pathologic Assessment and BenefitCurrent Colorectal Cancer Reports 2016; 12(4): 208 doi: 10.1007/s11888-016-0326-5
2
Hasan Ahmad Albitar, Yahya Almodallal, Rick Nishimura, Vivek N. Iyer. Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous BevacizumabMayo Clinic Proceedings: Innovations, Quality & Outcomes 2020;  doi: 10.1016/j.mayocpiqo.2020.01.002
3
Zipeng Lu, Maximilian Weniger, Kuirong Jiang, Stefan Boeck, Kai Zhang, Alexander Bazhin, Yi Miao, Jens Werner, Jan G. D’Haese. Therapies Targeting the Tumor Stroma and the VEGF/VEGFR Axis in Pancreatic Ductal Adenocarcinoma: a Systematic Review and Meta-AnalysisTargeted Oncology 2018; 13(4): 447 doi: 10.1007/s11523-018-0578-x
4
Sabina Palma, Ariel O. Zwenger, María V. Croce, Martín C. Abba, Ezequiel Lacunza. From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer TherapyClinical Colorectal Cancer 2016; 15(2): 104 doi: 10.1016/j.clcc.2015.11.001
5
M. Di Nisio, M. Candeloro, A. W. S. Rutjes, E. Porreca. Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysisJournal of Thrombosis and Haemostasis 2018; 16(7): 1336 doi: 10.1111/jth.14149
6
Alexander Baraniskin, Barbara Buchberger, Christian Pox, Ulli Graeven, Julian W. Holch, Wolff Schmiegel, Volker Heinemann. Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysisEuropean Journal of Cancer 2019; 106: 37 doi: 10.1016/j.ejca.2018.10.009
7
Minsu Lee, Jin-Young Choi, Joon Seok Lim, Mi-Suk Park, Myeong-Jin Kim, Honsoul Kim. Lack of anti-tumor activity by anti-VEGF treatments in hepatic hemangiomasAngiogenesis 2016; 19(2): 147 doi: 10.1007/s10456-016-9494-9
8
Matthieu Siebert, Mohammad Alyami, Frederic Mercier, Colin Gallice, Laurent Villeneuve, Nathalie Laplace, Guillaume Passot, Naoual Bakrin, Olivier Glehen, Vahan Kepenekian. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in association with systemic chemotherapy and bevacizumab, evaluation of safety and feasibility. A single center comparative studyEuropean Journal of Surgical Oncology 2019;  doi: 10.1016/j.ejso.2019.03.021
9
Jinhai Huang, Wenwen Wang, Jing Yu, Xinxin Yu, Qianqian Zheng, Fangli Peng, Zhifen He, Wenguang Zhao, Zhaoliang Zhang, Xingyi Li, Qinmei Wang. Combination of dexamethasone and Avastin® by supramolecular hydrogel attenuates the inflammatory corneal neovascularization in rat alkali burn modelColloids and Surfaces B: Biointerfaces 2017; 159: 241 doi: 10.1016/j.colsurfb.2017.07.057
10
Selma Yaman, Nursima Çukadar, Furkan Baran, Fatih Burak Uyanık, Metin Kılınç, Tufan Mert. Monoklonal antikorlardan bevacizumab'ın deneysel inflamatuar ağrı modelinde antianjiyogenik etkisiCukurova Medical Journal 2019; 44: 33 doi: 10.17826/cumj.532813
11
F.I. Mulder, N. van Es, N. Kraaijpoel, M. Di Nisio, M. Carrier, A. Duggal, M. Gaddh, D. Garcia, M.A. Grosso, A.K. Kakkar, M.F. Mercuri, S. Middeldorp, G. Royle, A. Segers, S. Shivakumar, P. Verhamme, T. Wang, J.I. Weitz, G. Zhang, H.R. Büller, G. Raskob. Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer studyThrombosis Research 2020; 185: 13 doi: 10.1016/j.thromres.2019.11.007
12
Lidia Rita Corsini, Daniele Fanale, Francesco Passiglia, Lorena Incorvaia, Vincenzo Gennusa, Viviana Bazan, Antonio Russo. Monoclonal antibodies for the treatment of non-hematological tumors: a safety reviewExpert Opinion on Drug Safety 2018; 17(12): 1197 doi: 10.1080/14740338.2018.1550068
13
Tijl Vermassen, Karen Geboes, Marc De Man, Stéphanie Laurent, Elsie Decoene, Nicolaas Lumen, Joris Delanghe, Sylvie Rottey. Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agentsNephrology Dialysis Transplantation 2018; 33(3): 402 doi: 10.1093/ndt/gfx063
14
Erdem Bangi, Celina Ang, Peter Smibert, Andrew V. Uzilov, Alexander G. Teague, Yevgeniy Antipin, Rong Chen, Chana Hecht, Nelson Gruszczynski, Wesley J. Yon, Denis Malyshev, Denise Laspina, Isaiah Selkridge, Hope Rainey, Aye S. Moe, Chun Yee Lau, Patricia Taik, Eric Wilck, Aarti Bhardwaj, Max Sung, Sara Kim, Kendra Yum, Robert Sebra, Michael Donovan, Krzysztof Misiukiewicz, Eric E. Schadt, Marshall R. Posner, Ross L. Cagan. A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancerScience Advances 2019; 5(5): eaav6528 doi: 10.1126/sciadv.aav6528
15
Cindy Neuzillet, Benoît Rousseau, Hemant Kocher, Philippe Bourget, Christophe Tournigand. Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomasPharmacology & Therapeutics 2017; 174: 145 doi: 10.1016/j.pharmthera.2017.02.028
16
Grigoris T. Gerotziafas, Ismail Elalamy. Risque thromboembolique en oncologie : réalités, actualités et perspectivesBulletin du Cancer 2016; 103(9): 764 doi: 10.1016/j.bulcan.2016.07.001
17
Yuta Hara, Ryota Torii, Shiho Ueda, Erina Kurimoto, Eri Ueda, Hiroshi Okura, Yutaka Tatano, Hideki Yagi, Yoshiya Ohno, Toshiyuki Tanaka, Kazue Masuko, Takashi Masuko. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1Cancer Science 2018; 109(10): 3171 doi: 10.1111/cas.13755
18
Jae Hyun Kim, Seun Ja Park. Target Therapy in Unresectable or Metastatic Colorectal CancerThe Korean Journal of Gastroenterology 2016; 68(6): 303 doi: 10.4166/kjg.2016.68.6.303
19
Hakan Kulacoglu, Ferdinand Köckerling. Hernia and Cancer: The Points Where the Roads IntersectFrontiers in Surgery 2019; 6 doi: 10.3389/fsurg.2019.00019
20
Prashanth Rawla, Adam Barsouk, Andreas V. Hadjinicolaou, Alexander Barsouk. Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal CancerMedical Sciences 2019; 7(8): 83 doi: 10.3390/medsci7080083
21
Lee S. Rosen, Ira A. Jacobs, Ronald L. Burkes. Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of BiosimilarsTargeted Oncology 2017; 12(5): 599 doi: 10.1007/s11523-017-0518-1
22
Philip Emmerich, Linda Clipson, Dustin A. Deming. Resistance Mechanisms to Colorectal Cancer Therapeutics and the Clinical ImplicationsCurrent Colorectal Cancer Reports 2017; 13(4): 334 doi: 10.1007/s11888-017-0374-5
23
Courtney S. Malo, Roman H. Khadka, Katayoun Ayasoufi, Fang Jin, Jackson E. AbouChehade, Michael J. Hansen, Raymond Iezzi, Kevin D. Pavelko, Aaron J. Johnson. Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental GliomaFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00320
24
Helga Hagman, Pär-Ola Bendahl, Jon Lidfeldt, Mattias Belting, Anders Johnsson, Aamir Ahmad. Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancerPLOS ONE 2018; 13(12): e0209838 doi: 10.1371/journal.pone.0209838
25
Giandomenico Roviello, Chiara Pacifico, Paola Corona, Daniele Generali. Risk of hypertension with ramucirumab-based therapy in solid tumors: data from a literature based meta-analysisInvestigational New Drugs 2017; 35(4): 518 doi: 10.1007/s10637-017-0452-1
26
Christina E. Bailey, Alexander A. Parikh. Assessment of the risk of antiangiogenic agents before and after surgeryCancer Treatment Reviews 2018; 68: 38 doi: 10.1016/j.ctrv.2018.05.002
27
Jorge Pablo Grondona. Extreme Hepatic Surgery and Other Strategies2017; : 79 doi: 10.1007/978-3-319-13896-1_6
28
Marco Ravanelli, Giorgio Maria Agazzi, Elena Tononcelli, Elisa Roca, Paolo Cabassa, Gianluca Baiocchi, Alfredo Berruti, Roberto Maroldi, Davide Farina. Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapyLa radiologia medica 2019; 124(9): 877 doi: 10.1007/s11547-019-01046-4
29
Tobias Engel Ayer Botrel, Luciana Gontijo de Oliveira Clark, Luciano Paladini, Otávio Augusto C. Clark. Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysisBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2734-y
30
Luisa Seguella, Riccardo Capuano, Mirella Pesce, Giuseppe Annunziata, Marcella Pesce, Barbara de Conno, Giovanni Sarnelli, Laura Aurino, Giuseppe Esposito. S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 CellsInternational Journal of Molecular Sciences 2019; 20(13): 3240 doi: 10.3390/ijms20133240
31
Dengfeng Wang, Yang Yu, Pengxian Tao, Dan Wang, Yajing Chen, Hao Chen. Risk of venous thromboembolism in patients undergoing gastric cancer surgery: protocol for a systematic review and meta-analysisBMJ Open 2020; 10(1): e033267 doi: 10.1136/bmjopen-2019-033267